Carregant...
Recent Progress in the Prevention of Serogroup B Meningococcal Disease
The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge of providing protection against serogroup B disease. Over a period of 4 decades, vaccine development has focused on subcapsular protein antigens, first with outer membrane vesicle (OMV) vaccines again...
Guardat en:
| Publicat a: | Clin Vaccine Immunol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5424234/ https://ncbi.nlm.nih.gov/pubmed/28356256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00566-16 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|